55 related articles for article (PubMed ID: 38535989)
1. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
2. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
[TBL] [Abstract][Full Text] [Related]
3. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
Ji Q; Guo Y; Li Z; Zhang X
Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
5. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
7. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
[TBL] [Abstract][Full Text] [Related]
8. Quercetin induces MGMT
Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
[TBL] [Abstract][Full Text] [Related]
9. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
Zou Y; Zheng S; Xie X; Ye F; Hu X; Tian Z; Yan SM; Yang L; Kong Y; Tang Y; Tian W; Xie J; Deng X; Zeng Y; Chen ZS; Tang H; Xie X
Nat Commun; 2022 May; 13(1):2672. PubMed ID: 35562334
[TBL] [Abstract][Full Text] [Related]
11. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
12. Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.
Maskalenko NA; Zhigarev D; Campbell KS
Nat Rev Drug Discov; 2022 Aug; 21(8):559-577. PubMed ID: 35314852
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
Hezaveh K; Shinde RS; Klötgen A; Halaby MJ; Lamorte S; Ciudad MT; Quevedo R; Neufeld L; Liu ZQ; Jin R; Grünwald BT; Foerster EG; Chaharlangi D; Guo M; Makhijani P; Zhang X; Pugh TJ; Pinto DM; Co IL; McGuigan AP; Jang GH; Khokha R; Ohashi PS; O'Kane GM; Gallinger S; Navarre WW; Maughan H; Philpott DJ; Brooks DG; McGaha TL
Immunity; 2022 Feb; 55(2):324-340.e8. PubMed ID: 35139353
[TBL] [Abstract][Full Text] [Related]
14. WTAP-mediated m
Li ZX; Zheng ZQ; Yang PY; Lin L; Zhou GQ; Lv JW; Zhang LL; Chen F; Li YQ; Wu CF; Li F; Ma J; Liu N; Sun Y
Cell Death Differ; 2022 Jun; 29(6):1137-1151. PubMed ID: 34999731
[TBL] [Abstract][Full Text] [Related]
15. HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells.
Da C; Pu J; Liu Z; Wei J; Qu Y; Wu Y; Shi B; Yang J; He N; Hou P
Signal Transduct Target Ther; 2021 Nov; 6(1):399. PubMed ID: 34815381
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
